Acrivon Therapeutics Inc
NASDAQ:ACRV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Acrivon Therapeutics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Acrivon Therapeutics Does
Acrivon Therapeutics is a biotechnology company that develops precision cancer medicines. It is not a commercial drugmaker yet; it builds drug candidates for hard-to-treat solid tumors and tries to match those drugs to patients whose tumors are more likely to respond. Its core idea is to use tumor biology, not just the cancer’s location, to guide treatment.
- Headquarters
- United States of America US
- Employees
- 39
- IPO date
- Nov 15, 2022
Balance Sheet
Continue ACRV Research
Decided on Acrivon Therapeutics? Get an email when ACRV reaches the price you’d buy at. Free with an account.